======= HTRA1 ======= == Gene Information == * **Official Symbol**: HTRA1 * **Official Name**: HtrA serine peptidase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5654|5654]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92743|Q92743]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HTRA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HTRA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602194|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Serine protease with a variety of targets, including extracellular matrix proteins such as fibronectin. HTRA1-generated fibronectin fragments further induce synovial cells to up-regulate MMP1 and MMP3 production. May also degrade proteoglycans, such as aggrecan, decorin and fibromodulin. Through cleavage of proteoglycans, may release soluble FGF-glycosaminoglycan complexes that promote the range and intensity of FGF signals in the extracellular space. Regulates the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. Inhibits signaling mediated by TGF-beta family members. This activity requires the integrity of the catalytic site, although it is unclear whether TGF-beta proteins are themselves degraded. By acting on TGF-beta signaling, may regulate many physiological processes, including retinal angiogenesis and neuronal survival and maturation during development. Intracellularly, degrades TSC2, leading to the activation of TSC2 downstream targets. {ECO:0000269|PubMed:16377621, ECO:0000269|PubMed:20671064, ECO:0000269|PubMed:9852107}. |PDZ| |IGFBP| |Kazal 2| |Trypsin| |Kazal 1| |chorionic trophoblast cell differentiation| |dentinogenesis| |chorion development| |extraembryonic membrane development| |insulin-like growth factor binding| |negative regulation of defense response to virus| |negative regulation of BMP signaling pathway| |serine-type peptidase activity| |extracellular matrix disassembly| |negative regulation of transforming growth factor beta receptor signaling pathway| |regulation of defense response to virus| |negative regulation of cellular response to transforming growth factor beta stimulus| |odontogenesis of dentin-containing tooth| |regulation of BMP signaling pathway| |negative regulation of response to biotic stimulus| |regulation of transforming growth factor beta receptor signaling pathway| |negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of cellular response to transforming growth factor beta stimulus| |odontogenesis| |negative regulation of immune effector process| |negative regulation of cellular response to growth factor stimulus| |placenta development| |serine-type endopeptidase activity| |positive regulation of epithelial cell proliferation| |negative regulation of defense response| |negative regulation of multi-organism process| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of cellular response to growth factor stimulus| |regulation of epithelial cell proliferation| |extracellular matrix organization| |collagen-containing extracellular matrix| |negative regulation of response to external stimulus| |extracellular structure organization| |cellular component disassembly| |reproductive structure development| |reproductive system development| |negative regulation of immune system process| |regulation of immune effector process| |regulation of response to biotic stimulus| |developmental process involved in reproduction| |regulation of defense response| |regulation of multi-organism process| |anatomical structure formation involved in morphogenesis| |positive regulation of cell population proliferation| |animal organ morphogenesis| |identical protein binding| |regulation of response to external stimulus| |negative regulation of signal transduction| |proteolysis| |negative regulation of cell communication| |negative regulation of signaling| |reproductive process| |reproduction| |regulation of response to stress| |extracellular space| |regulation of cell population proliferation| |negative regulation of response to stimulus| |regulation of immune system process| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp494|Isoniazid 100μM R08 exp494]]|-1.77| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15156 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}